@dansfera: The ultimate biotech reality check: Phase 2 is the make-or-break moment. This is where efficacy testing becomes the graveyard for most drug candidates—only a shocking 30% actually pass to Phase 3! 🤯 Smart money watches the pipeline stage *very* closely. Know the biggest risk factor before you pick your next pharma stock. #Biotech #Investing #ClinicalTrials #StockMarket #Pharma